MERUS N V's ticker is MRUS and the CUSIP is N5749R100. A total of 92 filers reported holding MERUS N V in Q4 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,221,999 | +30.4% | 179,050 | +45.6% | 0.00% | – |
| Q2 2023 | $3,238,774 | +44.6% | 123,007 | +1.1% | 0.00% | – |
| Q1 2023 | $2,239,758 | +18.9% | 121,726 | 0.0% | 0.00% | – |
| Q4 2022 | $1,883,101 | -25.6% | 121,726 | -3.6% | 0.00% | – |
| Q3 2022 | $2,530,000 | +0.9% | 126,266 | +14.0% | 0.00% | – |
| Q2 2022 | $2,507,000 | -21.6% | 110,716 | -8.4% | 0.00% | – |
| Q1 2022 | $3,196,000 | -16.4% | 120,889 | +0.5% | 0.00% | – |
| Q4 2021 | $3,824,000 | +37.5% | 120,251 | -4.9% | 0.00% | – |
| Q3 2021 | $2,782,000 | +19.0% | 126,436 | +14.0% | 0.00% | – |
| Q2 2021 | $2,338,000 | +38.6% | 110,932 | +37.4% | 0.00% | – |
| Q1 2021 | $1,687,000 | +74.1% | 80,732 | +46.1% | 0.00% | – |
| Q4 2020 | $969,000 | +50.5% | 55,254 | +2.8% | 0.00% | – |
| Q3 2020 | $644,000 | -28.7% | 53,741 | -4.3% | 0.00% | – |
| Q2 2020 | $903,000 | – | 56,150 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 1,600,000 | $33,712,000 | 6.04% |
| BVF INC/IL | 7,285,071 | $153,496,000 | 5.75% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 320,815 | $6,760,000 | 3.02% |
| Burrage Capital Management LLC | 130,683 | $2,753,000 | 2.76% |
| MPM BioImpact LLC | 700,879 | $14,768,000 | 2.43% |
| Boxer Capital, LLC | 1,900,000 | $40,033,000 | 1.41% |
| Octagon Capital Advisors LP | 206,927 | $4,360,000 | 0.90% |
| DAFNA Capital Management LLC | 157,841 | $3,326,000 | 0.70% |
| Ghost Tree Capital, LLC | 75,000 | $1,580,000 | 0.43% |
| SPHERA FUNDS MANAGEMENT LTD. | 286,506 | $6,037,000 | 0.41% |